BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (BCRX) will present at the 6th Annual Evercore ISI HealthCONx Conference on November 28th and the 35th Annual Piper Sandler Healthcare Conference on November 29th, 2023. The live audio webcasts and replays will be available on the company's website.
11/21/2023 - 04:01 PM
RESEARCH TRIANGLE PARK, N.C., Nov. 21, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28th in Miami at 9:35 a.m. ET and the 35th Annual Piper Sandler Healthcare Conference on Wednesday, November 29th in New York at 12:30 p.m. ET.
Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com .
About BioCryst Pharmaceuticals ® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact : jbluth@biocryst.com
BioCryst Pharmaceuticals, Inc. will present at the Evercore ISI HealthCONx Conference on November 28th, 2023.
The live audio webcasts and replays of BioCryst Pharmaceuticals, Inc.'s presentations can be accessed in the Investors & Media section of the company's website at http://www.biocryst.com.
The ticker symbol for BioCryst Pharmaceuticals, Inc. is BCRX.
The 35th Annual Piper Sandler Healthcare Conference is an industry event where BioCryst Pharmaceuticals, Inc. will present on November 29th, 2023.
BioCryst Pharmaceuticals, Inc. will present at the 35th Annual Piper Sandler Healthcare Conference in New York at 12:30 p.m. ET on November 29th, 2023.
Biocryst Pharmaceuticals Inc.
BCRX Rankings
#4914 Ranked by Stock Gains
BCRX Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Durham
About BCRX
biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.
